Thanks for the TU, I was beginning to think everyone was afraid of stuff that shows how good Polynovo is.
Consider this about Systagenix and its` history since being acquired from J&J. CZD are a bargain at sub .09c for a Private Equity Fund.
About Systagenix Systagenix is a global leader in innovative wound care established in 2008 following the acquisition of Johnson & Johnson’s professional wound care business by One Equity Partners. Systagenix is 100% dedicated to wound care, developing and marketing advanced wound diagnostic and therapeutic solutions and supplying over 20 million advanced wound dressings per month globally. Systagenix’ longstanding commitment to skin and wound care began with innovative wound care treatments developed by the experienced team of R&D Scientists at the Gargrave Centre of Excellence for Wound Healing in North Yorkshire, England. With approximately 800 employees worldwide, Systagenix distributes products and services to more than 100 countries.
CZD Price at posting:
8.7¢ Sentiment: Buy Disclosure: Held
